Chemoradiation for Patients with Resected Biliary Tract Cancers in the Adjuvant Setting: Reply to a Letter to the Editor
Ann Surg Oncol
.
2020 Dec;27(Suppl 3):937-939.
doi: 10.1245/s10434-020-09130-0.
Epub 2020 Sep 10.
Authors
Edward Christopher Dee
1
,
Morgan E Freret
2
,
Jennifer Y Wo
3
4
Affiliations
1
Harvard Medical School, Boston, MA, USA.
2
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
3
Harvard Medical School, Boston, MA, USA. jwo@mgh.harvard.edu.
4
Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. jwo@mgh.harvard.edu.
PMID:
32910277
DOI:
10.1245/s10434-020-09130-0
No abstract available
Publication types
Letter
Comment
MeSH terms
Biliary Tract Neoplasms* / therapy
Chemoradiotherapy
Chemotherapy, Adjuvant
Humans